科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ International Immunopharmacology2026-02-26· Medicine

A severe case of rhabdomyolysis, acute kidney injury, cardiogenic shock, and chronic complications caused by an excessively large dose of Tripterygium glycoside

Shanfu Lu, Huan Zhong, Kangkang Zhou, Wei Li, Yan Zhu, Wenlv Tang, BingLan Yang, Chao Xue

原始摘要(英文原文)· Original abstract
Tripterygium wilfordii Hook F. (TwHF) is a traditional Chinese medicine that has been used for centuries. Tripterygium glycoside (TG), a herbal agent extracted from the TwHF rhizome, is extensively used for the treatment of systemic lupus erythematosus, rheumatoid arthritis, nephrotic syndrome, and atopic eczema. However, its clinical application is hindered by its multi-target toxicity. Current literature highlights multiple TG-related complications, including acute liver and kidney injury, rhabdomyolysis, infertility, and lymphocyte suppression. Contrarily, concurrent severe rhabdomyolysis, acute kidney injury (AKI), and cardiogenic shock are rarely reported in cases of TG poisoning. Here, we present the case of a 50-year-old male with type 2 diabetes mellitus (T2DM) who experienced fatigue, nausea, vomiting, rhabdomyolysis, AKI, and cardiogenic shock after mistakenly consuming an excessive dose of TG. The patient consumed 20 tablets (10 mg/tablet) three times daily instead of the recommended therapeutic dose of 20 mg three times daily. Six months later, the patient developed TG-induced chronic complications, including chronic kidney disease (stage 2), polyuria, and irreversible nerve damage. Physicians must be vigilant about the potential for TG-induced life-threatening complications, and further studies are needed to elucidate the dose-effect relationship and establish a safe dosage.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

A severe case of rhabdomyolysis, acute kidney injury, cardiogenic shock, and chronic complications caused by an excessively large dose of Tripterygium glycoside — 科研速览 Science Skim